Related Experiment Videos
Variable phenotypes in patients diagnosed with idiopathic multifocal choroiditis.
Robert E MacLaren1, Susan L Lightman
1Moorfields Eye Hospital, City Road, London, UK. maclaren@herald.ox.ac.uk
Clinical & Experimental Ophthalmology
|May 5, 2006
Summary
Idiopathic multifocal choroiditis (MFC) investigations revealed no distinct new phenotype. Most patients maintained good vision long-term and responded well to oral steroids, indicating a favorable prognosis.
Area of Science:
- Ophthalmology
- Uveitis
- Retinal Diseases
Background:
- Idiopathic multifocal choroiditis (MFC) is a rare inflammatory eye condition.
- Understanding its clinical phenotype and long-term prognosis is crucial for patient management.
Purpose of the Study:
- To identify a potential new clinical phenotype in idiopathic MFC.
- To determine the long-term visual prognosis for patients with idiopathic MFC.
Main Methods:
- Retrospective review of 28 patients diagnosed with idiopathic MFC.
- Ocular examination including fluorescein angiography.
- Comparison of visual outcomes, demographics, symptoms, lesion patterns, and complications.
Main Results:
- Approximately 60% of patients maintained best-corrected visual acuity for 10 years.
- Choroidal neovascularization and cystoid macular edema were associated with poor vision.
- Most patients (10/11) responded positively to oral steroid treatment.
Conclusions:
- No distinct new phenotype emerged in this cohort of idiopathic MFC.
- The visual prognosis for idiopathic MFC is generally good.
- Oral steroids are an effective treatment for most cases.